Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ying Li, Meng Wang, Bu-Wei Huang, Yuan Ping, Jian You & Jian-Qing Gao. (2017) Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery. International Journal of Nanomedicine 12, pages 8557-8572.
Read now
Read now
Santosh Kumar Singh, Shriti Singh, James W Lillard$suffix/text()$suffix/text() & Rajesh Singh. (2017) Drug delivery approaches for breast cancer. International Journal of Nanomedicine 12, pages 6205-6218.
Read now
Read now
Yueling Yuan, Tiange Cai, Xi Xia, Ronghua Zhang, Peter Chiba & Yu Cai. (2016) Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer. Drug Delivery 23:9, pages 3350-3357.
Read now
Read now
Anjali Apte, Erez Koren, Alexander Koshkaryev & Vladimir P Torchilin. (2014) Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models. Cancer Biology & Therapy 15:1, pages 69-80.
Read now
Read now
Rassoul Dinarvand, Reyhaneh Varshochian, Golnaz Kamalinia, Navid Goodarzi & Fatemeh Atyabi. (2013) Recent approaches to overcoming multiple drug resistance in breast cancer using modified liposomes. Clinical Lipidology 8:4, pages 391-394.
Read now
Read now
Chung Kil Song, Prabarga Balakrishnan, Chang-Koo Shim, Suk-Jae Chung & Dae-Duk Kim. (2011) Enhanced in vitro cellular uptake of P-gp substrate by poloxamer-modified liposomes (PMLs) in MDR cancer cells. Journal of Microencapsulation 28:6, pages 575-581.
Read now
Read now
Articles from other publishers (22)
Sumel Ashique, Ashish Garg, Afzal Hussain, Arshad Farid, Prashant Kumar & Farzad Taghizadeh‐Hesary. (2023) Nanodelivery systems: An efficient and target‐specific approach for drug‐resistant cancers. Cancer Medicine.
Crossref
Crossref
Ali H. Alamri, Sandip Debnath, Taha Alqahtani, Ali Alqahtani, Saad Ali Alshehri & Arabinda Ghosh. (2023) Enhancing plant-derived smart nano inhibitor in targeting mammalian target of rapamycin (mTOR) in breast cancer using Curcuma longa-derived compound curcumin. Environmental Science and Pollution Research.
Crossref
Crossref
Penghui Wang, Yuling Wang, Xuelin Xia, Wei Huang & Deyue Yan. (2023)
Redox-responsive drug-inhibitor conjugate encapsulated in DSPE-PEG
2k
micelles for overcoming multidrug resistance to chemotherapy
. Biomaterials Science.
Crossref
Crossref
Kazem Nejati, Mojgan Rastegar, Farzaneh Fathi, Mehdi Dadashpour & AmirAhmad Arabzadeh. (2022) Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance. Journal of Drug Delivery Science and Technology 70, pages 103231.
Crossref
Crossref
Emma Grabarnick (Portnoy)Alexander V. Andriyanov, Hadas Han, Sara Eyal & Yechezkel Barenholz. (2021) PEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors. Pharmaceutics 13:12, pages 2181.
Crossref
Crossref
Arun Radhakrishnan, Gowthamarajan Kuppusamy, Sivasankaran Ponnusankar & Srinivas Mutalik. (2021) Towards next-generation personalization of tacrolimus treatment: a review on advanced diagnostic and therapeutic approaches. Pharmacogenomics 22:17, pages 1151-1175.
Crossref
Crossref
Loveleen Kaur, Harvinder S. Sohal, Manvinder Kaur, Dharambeer S. Malhi & Sonali Garg. (2020) A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry 20:17, pages 2012-2024.
Crossref
Crossref
Ali Sartaj, Sanjula Baboota & Javed Ali. (2020) Nanomedicine: A Promising Avenue for the Development of Effective Therapy for Breast Cancer. Current Cancer Drug Targets 20:8, pages 603-615.
Crossref
Crossref
Phuong Tran, Sang-Eun Lee, Dong-Hyun Kim, Yong-Chul Pyo & Jeong-Sook Park. (2019) Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment. Journal of Pharmaceutical Investigation 50:3, pages 261-270.
Crossref
Crossref
Pal Patel, Nikita Meghani, Krupa Kansara & Ashutosh Kumar. (2019) Nanotherapeutics for the Treatment of Cancer and Arthritis. Current Drug Metabolism 20:6, pages 430-445.
Crossref
Crossref
Marta Jedynak, David Laurin, Patryk Dolega, Malgorzata Podsiadla-Bialoskorska, Inga Szurgot, Jadwiga Chroboczek & Ewa Szolajska. (2018) Leukocytes and drug-resistant cancer cells are targets for intracellular delivery by adenoviral dodecahedron. Nanomedicine: Nanotechnology, Biology and Medicine 14:6, pages 1853-1865.
Crossref
Crossref
Manjarika De, Sneha Ghosh, Triparna Sen, Md. Shadab, Indranil Banerjee, Santanu Basu & Nahid Ali. (2018) A Novel Therapeutic Strategy for Cancer Using Phosphatidylserine Targeting Stearylamine-Bearing Cationic Liposomes. Molecular Therapy - Nucleic Acids 10, pages 9-27.
Crossref
Crossref
Manu S. Singh, Salma N. Tammam, Maryam A. Shetab Boushehri & Alf Lamprecht. (2017) MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers. Pharmacological Research 126, pages 2-30.
Crossref
Crossref
YINGHONG HUANG, SUSAN P.C. COLE, TIANGE CAI & YU CAI. (2016) Applications of nanoparticle drug delivery systems for the reversal of multidrug resistance in cancer. Oncology Letters 12:1, pages 11-15.
Crossref
Crossref
Joanna Kopecka, Giuseppina Salzano, Ivana Campia, Sara Lusa, Dario Ghigo, Giuseppe De Rosa & Chiara Riganti. (2014) Insights in the chemical components of liposomes responsible for P-glycoprotein inhibition. Nanomedicine: Nanotechnology, Biology and Medicine 10:1, pages 77-87.
Crossref
Crossref
Budhaditya MukherjeeRupkatha MukhopadhyayBijoylaxmi BannerjeeSayan ChowdhurySandip MukherjeeKshudiram NaskarUday Sankar AllamDipshikha ChakravorttyShyam SundarJean-Claude Dujardin & Syamal Roy. (2013)
Antimony-resistant but not antimony-sensitive
Leishmania donovani
up-regulates host IL-10 to overexpress multidrug-resistant protein 1
. Proceedings of the National Academy of Sciences 110:7.
Crossref
Crossref
Marketa Ryvolova, Jana Drbohlavova, Kristyna Smerkova, Jana Chomoucka, Pavlina Sobrova, Vojtech Adam, Pavel Kopel, Jaromir Hubalek & Rene Kizek. 2013. Nanomedicine for Drug Delivery and Therapeutics. Nanomedicine for Drug Delivery and Therapeutics
471
492
.
Keita Un, Kumiko Sakai-Kato, Yuki Oshima, Toru Kawanishi & Haruhiro Okuda. (2012) Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomes. Biomaterials 33:32, pages 8131-8141.
Crossref
Crossref
Rene Kizek, Vojtech Adam, Jan Hrabeta, Tomas Eckschlager, Svatopluk Smutny, Jaroslav V. Burda, Eva Frei & Marie Stiborova. (2012) Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances. Pharmacology & Therapeutics 133:1, pages 26-39.
Crossref
Crossref
Chiara Riganti, Claudia Voena, Joanna Kopecka, Paola Antonia Corsetto, Gigliola Montorfano, Emanuele Enrico, Costanzo Costamagna, Angela Maria Rizzo, Dario Ghigo & Amalia Bosia. (2011) Liposome-Encapsulated Doxorubicin Reverses Drug Resistance by Inhibiting P-Glycoprotein in Human Cancer Cells. Molecular Pharmaceutics 8:3, pages 683-700.
Crossref
Crossref
Jayeeta Roychoudhury, Roma Sinha & Nahid Ali. (2011) Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice. PLoS ONE 6:3, pages e17376.
Crossref
Crossref
Joanna Kopecka, Ivana Campia, Paolo Olivero, Gianpiero Pescarmona, Dario Ghigo, Amalia Bosia & Chiara Riganti. (2011) A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells. Journal of Controlled Release 149:2, pages 196-205.
Crossref
Crossref